Analytical model for out-of-field dose in photon craniospinal irradiation
- 8 October 2013
- journal article
- research article
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 58 (21) , 7463-7479
Abstract
The prediction of late effects after radiotherapy in organs outside a treatment field requires accurate estimations of out-of-field dose. However, out-of-field dose is not calculated accurately by commercial treatment planning systems (TPSs). The purpose of this study was to develop and test an analytical model for out-of-field dose during craniospinal irradiation (CSI) from photon beams produced by a linear accelerator. In two separate evaluations of the model, we measured absorbed dose for a 6 MV CSI using thermoluminescent dosimeters placed throughout an anthropomorphic phantom and fit the measured data to an analytical model of absorbed dose versus distance outside of the composite field edge. These measurements were performed in two separate clinics—the University of Texas MD Anderson Cancer Center (MD Anderson) and the American University of Beirut Medical Center (AUBMC)—using the same phantom but different linear accelerators and TPSs commissioned for patient treatments. The measurement at AUBMC also included in-field locations. Measured dose values were compared to those predicted by TPSs and parameters were fit to the model in each setting. In each clinic, 95% of the measured data were contained within a factor of 0.2 and one root mean square deviation of the model-based values. The root mean square deviations of the mathematical model were 0.91 cGy Gy−1 and 1.67 cGy Gy−1 in the MD Anderson and AUBMC clinics, respectively. The TPS predictions agreed poorly with measurements in regions of sharp dose gradient, e.g., near the field edge. At distances greater than 1 cm from the field edge, the TPS underestimated the dose by an average of 14% ± 24% and 44% ± 19% in the MD Anderson and AUBMC clinics, respectively. The in-field measured dose values of the measurement at AUBMC matched the dose values calculated by the TPS to within 2%. Dose algorithms in TPSs systematically underestimated the actual out-of-field dose. Therefore, it is important to use an improved model based on measurements when estimating out-of-field dose. The model proposed in this study performed well for this purpose in two clinics and may be applicable in other clinics with similar treatment field configurations.Keywords
This publication has 57 references indexed in Scilit:
- Comparison of second cancer risk due to out-of-field doses from 6-MV IMRT and proton therapy based on 6 pediatric patient treatment plansRadiotherapy and Oncology, 2011
- Predicted risks of second malignant neoplasm incidence and mortality due to secondary neutrons in a girl and boy receiving proton craniospinal irradiationPhysics in Medicine & Biology, 2010
- Risk of second malignant neoplasm following proton versus intensity-modulated photon radiotherapies for hepatocellular carcinomaPhysics in Medicine & Biology, 2010
- Effect of organ size and position on out-of-field dose distributions during radiation therapyPhysics in Medicine & Biology, 2010
- Accuracy of out-of-field dose calculations by a commercial treatment planning systemPhysics in Medicine & Biology, 2010
- An analytic model of neutron ambient dose equivalent and equivalent dose for proton radiotherapyPhysics in Medicine & Biology, 2010
- Comparison of out-of-field photon doses in 6 MV IMRT and neutron doses in proton therapy for adult and pediatric patientsPhysics in Medicine & Biology, 2010
- Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): An Introduction to the Scientific IssuesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Frequency Distribution of Second Solid Cancer Locations in Relation to the Irradiated Volume Among 115 Patients Treated for Childhood CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Monte Carlo modeling of a 6 and 18 MV Varian Clinac medical accelerator for in-field and out-of-field dose calculations: development and validationPhysics in Medicine & Biology, 2009